| Literature DB >> 24954501 |
Travis Bui-Klimke1, Felicia Wu.
Abstract
Balkan endemic nephropathy (BEN) is a chronic, progressive wasting disease of the kidneys, endemic in certain rural regions of the Balkan nations Croatia, Serbia, Bulgaria, and Romania. It is irreversible and ultimately fatal. Though this disease was first described in the 1950s, its causes have been a mystery and a source of much academic and clinical contention. Possible etiologic agents that have been explored include exposure to metals and metalloids, viruses and bacteria, and the dietary toxins aristolochic acid (AA) and ochratoxin A (OTA). AA is a toxin produced by weeds of the genus Aristolochia, common in Balkan wheat fields. Aristolochia seeds may intermingle with harvested grains and thus inadvertently enter human diets. OTA is a mycotoxin (fungal toxin) common in many foods, including cereal grains. In this study, we analyzed the weight of evidence for each of the suspected causes of BEN using the Bradford Hill criteria (BHC): nine conditions that determine weight of evidence for a causal relationship between an agent and a disease. Each agent postulated to cause BEN was evaluated using the nine criteria, and for each criterion was given a rating based on the strength of the association between exposure to the substance and BEN. From the overall available scientific evidence for each of these suspected risk factors, AA is the agent with the greatest weight of evidence in causing BEN. We describe other methods for testing causality from epidemiological studies, which support this conclusion of AA causing BEN.Entities:
Keywords: Aristolochic acid; Balkan endemic nephropathy; Bradford Hill criteria; ochratoxin A; weight of evidence
Mesh:
Year: 2014 PMID: 24954501 PMCID: PMC4199864 DOI: 10.1111/risa.12239
Source DB: PubMed Journal: Risk Anal ISSN: 0272-4332 Impact factor: 4.000
Summary and Description of the Bradford Hill Criteria
| Criterion | Summary/Description |
|---|---|
| Strength | A strong association is more likely to have a causal component than is a modest association; higher correlation means there is a higher association between the agent and its effect |
| Consistency | A relationship is observed repeatedly; results are replicated in different studies using different methods |
| Specificity | A factor influences specifically a particular outcome/population; a single cause produces a specific effect |
| Temporality | The factor must always precede the outcome |
| Biological gradient/dose‐response relationship | The outcome increases monotonically with increasing dose of exposure; increasing exposure increases risk |
| Plausibility | The observed association can be plausibly explained by biological explanations |
| Coherence | A causal conclusion should not fundamentally contradict present knowledge |
| Experiment | Causation is more likely if evidence is based on randomized experiments |
| Analogy | For analogous exposures and outcomes, an effect has already been shown |
Evaluation of the Suspected Causes of Balkan Endemic Nephropathy, Using the Bradford Hill Criteria
| Aristolochic Acid | Ochratoxin A | Pliocene Coal/PAHs | Bacteria/Viruses | |
|---|---|---|---|---|
| Strength | AL‐DNA adducts in BEN patients renal tissues taking CHMs; no adducts in patients in nonendemic areas | OTA‐DNA adducts identified in UTTs of humans | PAHs detected in groundwater samples in endemic villages | Coronaviruses isolated from pigs associated with BEN |
| High | Moderate‐high | Moderate‐low | Low | |
| Consistency | Data consistent over geographic regionsBelgium, Taiwan, India | Inconsistent over geographic areasOTA detected at high levels in areas with no history of BEN | Inconsistent dataEndemic areas not associated with Pliocene coal | Inconsistent dataViral particles not isolated in all BEN patients |
| High | Low | Low | Low | |
| Specificity | The health outcomes for AA are specific to the urinary systems in humansAA has been associated with other adverse health outcomes such as ESRD, UTTs, and other transitional cell carcinomas | The health outcomes for AA are specific to the urinary systems in humansOTA has been associated with other adverse health outcomes such as ESRD, UTTs, nephritic syndrome, and other transitional cell carcinomas | The health outcomes for PAHs are not specific to BENPAHs such as pyrene, naphthalene, fluorine, and phenanthrene, which have been discovered in well water associated with Pliocene lignoites, have been associated with other adverse health outcomes; these outcomes include hemolytic anemia, kidney damage, liver damage, and jaundice, among others | The health outcomes for bacteria and viruses are not specific to BENLeptospira infections, coronaviruses, and papova viruses have all been associated with other adverse health endpoints other than BEN |
| High | High | Low | Low | |
| Temporality | Exposure precedes outcome unless genetic predisposition is proven | Exposure precedes outcome unless genetic predisposition is proven | Exposure precedes outcome unless genetic predisposition is proven | Exposure precedes outcome unless genetic predisposition is proven |
| High | High | High | No score | |
| Dose‐response relationship | Linear dose‐response relationship between UTTs and dose of AA in humans | Higher levels of OTA in blood and urine in BEN patients compared to healthy individuals | No dose‐response data exists in humansHigher levels of PAHs in BEN‐endemic areas compared to nonendemic areas | No dose‐response data exists in humans |
| High | Moderate | Low | No score | |
| Plausibility | AA forms adducts with DNA | OTA promotes adduct formation and increase DNA mutations | No specific mechanism proposed due to variety of PAHs found in water contaminated from Pliocene coal | Biologically plausible, no mechanistic data exists |
| Moderate‐high | Moderate | Low | Low | |
| Coherence | Coherent with the biology of BEN as a renal disease, AA and OTA specifically exert their toxicological effects in the renal system | Coherent with the biology of BEN as a renal disease, AA and OTA specifically exert their toxicological effects in the renal system | Not renal specific, but does not mean that the biological explanation that they may cause BEN is not coherent | Not renal specific, but does not mean that the biological explanation that they may cause BEN is not coherent |
| High | High | Moderate | Moderate | |
| Experiment | Laboratory evidence exists for animals; epidemiologic evidence exists for humans exposed to AA | Laboratory evidence exists for animals; | Only epidemiologic evidence exists correlating Pliocene coals, PAHs, and BEN | Varied laboratory data on animals exists; epidemiologic evidence shows some correlations between BEN and viruses/bacteria |
| High | Moderate | Low | Low | |
| Analogy | AA definitively linked to the CHN/AAN cases in Belgium | Adverse renal effects have been observed in laboratory animals administered OTA; there is no human disease similar to BEN that has definitively been linked to OTA exposure | Benzo[a]pyrene shown to cause liver and renal cancer in mice | Certain viruses have been linked to urothelial carcinoma |
| High | Moderate‐high | Moderate | Moderate | |
| Overall score | High: 8 | High: 3 | High: 1 | High: 0 |
| Moderate‐high: 1 | Moderate‐high: 2 | Moderate‐high: 0 | Moderate‐high: 0 | |
| Moderate: 0 | Moderate: 3 | Moderate: 2 | Moderate: 2 | |
| Moderate‐low: 0 | Moderate‐low: 0 | Moderate‐low: 1 | Moderate‐low: 0 | |
| Low: 0 | Low: 1 | Low: 5 | Low: 5 | |
| No score: 0 | No score: 0 | No score: 0 | No score: 2 |
AA = aristolohic acid; AL‐DNA = aristolactam‐DNA; BEN = Balkan endemic nephropathy; CHM = Chinese herbal medicines; ESRD = end‐stage renal disease; OTA = ochratoxin A; PAH = polycyclic aromatic hydrocarbons; UTT = urinary tract tumors.